Nalaganje...
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
Major progress has been made toward our understanding of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway (referred to as the PD pathway). mAbs are already being used to block the PD pathway to treat human cancers (anti-PD therapy), especially advanced solid tumors. This therapy...
Shranjeno v:
| izdano v: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588282/ https://ncbi.nlm.nih.gov/pubmed/26325035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80011 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|